Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of the "Feminine Identity Improvement Program" Based on Cognitive Behavioral and Expressive Techniques Applied to Gynecological Cancer Patients on Prolonged Grief Reactions and the "Perception of Femininity"

NCT05529303 is registered in ClinicalTrials.gov with Kevser Pamuk as lead sponsor.

NCT NCT05529303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05529303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of the "Feminine Identity Improvement Program" Based on Cognitive Behavioral and Expressive Techniques Applied to Gynecological Cancer Patients on Prolonged Grief Reactions and the "Perception of Femininity"
Lead sponsor
Kevser Pamuk
Phase
Not applicable
Overall status
Completed
Start date
February 26, 2023
Completion date
September 18, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervix cancer, endometrial cancer, femininity, grief, ovarian cancer, uterine cancer, vulva cancer